Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
JAMA|September 23, 2000
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromesD L Bhatt, E J TopolCurrent Cardiology Reports|January 5, 2001
Oral glycoprotein IIb/IIIa antagonists in coronary artery diseaseD P Chew, D L BhattMinerva Cardioangiologica|October 11, 2003
The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridinesJ C Hostetter, D L BhattThe Medical Clinics of North America|February 24, 2000
Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart diseaseD L Bhatt, E J TopolInternal Medicine Journal|June 29, 2002
Optimizing glycoprotein IIb/IIIa inhibition: lessons from recent randomized controlled trialsD P Chew, D L BhattAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Oral glycoprotein IIb/IIIa inhibitors: why don't they work?D P Chew, D L Bhatt, E J TopolPlastic and Reconstructive Surgery|July 1, 1990
Rhabdomyolysis due to pulsed electric fieldsD L Bhatt, D C Gaylor, R C LeeJournal of Women'S Health & Gender-Based Medicine|October 12, 2000
Optimizing percutaneous coronary revascularization in diabetic women: analysis from the EPISTENT trialL Cho, S P Marso, D L Bhatt, et al.Circulation|February 24, 2001
Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: a meta-analysis of phase III multicenter randomized trialsD P Chew, D L Bhatt, S Sapp, et al.Cerebrovascular Diseases (Basel, Switzerland)|November 30, 2000
Update on clinical trials of antiplatelet therapy for cerebrovascular diseasesD L Bhatt, S R Kapadia, J S Yadav, et al.Pageof 6